Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boeckh

Showing results (511-520 of 692) with videos related to

Pageof 70
Sort By:
The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.
Parasites & Vectors|September 26, 2009
Effects of worm control practices examined by a combined faecal egg count and questionnaire survey on horse farms in Germany, Italy and the UKGeorg von Samson-Himmelstjerna, Donato Traversa, Janina Demeler, et al.
Bone Marrow Transplantation|May 6, 2025
ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipientsDanniel Zamora, Hu Xie, Elizabeth Wong, et al.
The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.
European Radiology Experimental|April 4, 2024
Multimaterial decomposition in dual-energy CT for characterization of clots from acute ischemic stroke patientsMelina Gassenhuber, Maximilian E Lochschmidt, Johannes Hammel, et al.
Open Forum Infectious Diseases|January 26, 2026
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for InfectionSara Pernikoff, Annelie Clurman, Melanie Rötepohl, et al.
The Journal of Infectious Diseases|August 26, 2017
Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome EvolutionChikara Ogimi, Alexander L Greninger, Alpana A Waghmare, et al.
Brain & Spine|November 25, 2024
Endovascular therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Single-center experience in a high-volume neurovascular unitCarolin Albrecht, Raimunde Liang, Dominik Trost, et al.
JCI Insight|August 5, 2024
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxisDanniel Zamora, Sayan Dasgupta, Terry Stevens-Ayers, et al.
Cardiovascular and Interventional Radiology|November 21, 2023
Interdisciplinary Rendez-Vous Approach in Endovascular Stroke Treatment: A New Concept to Accelerate Mechanical Thrombectomy in Primary Stroke CentersNadja Krug, Holger Braun, Andreas Knez, et al.
Pageof 70

Showing results (511-520 of 692) with videos related to

Sort By:
Pageof 70
The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.
Parasites & Vectors|September 26, 2009
Effects of worm control practices examined by a combined faecal egg count and questionnaire survey on horse farms in Germany, Italy and the UKGeorg von Samson-Himmelstjerna, Donato Traversa, Janina Demeler, et al.
Bone Marrow Transplantation|May 6, 2025
ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipientsDanniel Zamora, Hu Xie, Elizabeth Wong, et al.
The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.
European Radiology Experimental|April 4, 2024
Multimaterial decomposition in dual-energy CT for characterization of clots from acute ischemic stroke patientsMelina Gassenhuber, Maximilian E Lochschmidt, Johannes Hammel, et al.
Open Forum Infectious Diseases|January 26, 2026
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for InfectionSara Pernikoff, Annelie Clurman, Melanie Rötepohl, et al.
The Journal of Infectious Diseases|August 26, 2017
Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome EvolutionChikara Ogimi, Alexander L Greninger, Alpana A Waghmare, et al.
Brain & Spine|November 25, 2024
Endovascular therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Single-center experience in a high-volume neurovascular unitCarolin Albrecht, Raimunde Liang, Dominik Trost, et al.
JCI Insight|August 5, 2024
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxisDanniel Zamora, Sayan Dasgupta, Terry Stevens-Ayers, et al.
Cardiovascular and Interventional Radiology|November 21, 2023
Interdisciplinary Rendez-Vous Approach in Endovascular Stroke Treatment: A New Concept to Accelerate Mechanical Thrombectomy in Primary Stroke CentersNadja Krug, Holger Braun, Andreas Knez, et al.
Pageof 70